ACRO Biomedical Co., Ltd

▪ Distribution (代理/經銷)
▪ ODM/OEM (委託設計/製造/生產)
▪ R&D Collaboration (研發合作)
▪ Licensing (授權)

BIONET Corp.

CRDMO opportunities for regenerative medicine techniques, bioinformatic service, and precise medicine development with biomedicine companies.

CytoArm Co.,Ltd.

▪ Out-Licensing of Armed-T cell Technology and Products
▪ Clinical Trial Collaboration
▪ Fundraising

LumiSTAR Biotechnology, Inc.

▪ Out-Licensing
▪ Collaborative R&D for drug discovery
▪ Clinical collaboration on iPSC-based cell therapies

MycoMagic Biotechnology

▪ Out-Licensing
▪ Collaborative product development
▪ Academic/ Industry Research partner

OBI Pharma, Inc.

ADC platform technologies - OBI is looking for collaborative R&D and out-license opportunities to create first- or best-in-class ADCs.
OBI’s novel cancer therapeutics – OBI is seeking out-licensing opportunities to expedite the clinical development of our pipeline products.

PharmaEssentia Corp.

Licensing

PrecisemAb Biotech Co., Ltd.

▪ Cooperation Partners of Lead Product-PSM101
▪ Strategic Partners of ADC.
▪ Customized Antibody Lock design service
▪ Out-licensing of Lock-antibodies

Taiwan Universe BioMedicine

▪ Out-Licensing
▪ Collaborative R&D

Adimmune-Animmune

▪ CMO & CDMO Service
▪ Animal Vaccine Development

BRIM Biotechnology, Inc.

• Out-Licensing
• Co-development
• Investment

Formosa Pharmaceuticals, Inc.

Seeking out-licensing opportunities for leading pipeline assets.
Seeking co-development partner for Proprietary Platform.

PhytoHealth Corporation

• Out-licensing of PG2® and Oraphine®
• In-licensing of the products related to cancer supportive care, cancer therapy and neurology
• Co-develop inline products in new indications

T-E Meds, Inc.

• Series A fundraising
• Out-licensing ADC/ARC technology platforms to biotech, pharma, and CDMO
• Out-licensing TE-1146 ADC (anti-CD38 for multiple myeloma treatment) and TE-1132 ARC (anti-CA19-9 for pancreatic cancer diagnosis / treatment)
• Collaborations in research and development of ADC/ARC platforms

AnHorn Medicines Co., Ltd

Out-Licensing, Collaborative R&D

ARCE THERAPEUTICS, INC.

▪ CLL-1 CAR-T product early-entry to the market
▪ Seek partners to collaborate the U.S. and global clinical development
▪ Seek out-licensing opportunity

EARNING

• Preclinical development of drug discovery and medical device.
• Collaborative R&D.
• Contracted preclinical R&D, and comparative oncology trial.
• Translational marketing of veterinary clinical product and service.
• Investment.

EirGenix, Inc.

▪ Biologics CDMO- mAb, bispecific antibody, ADC, recombinant protein/peptide, plasmid DNA, RNA and viral vector
▪ Biologics CMO- commercial GMP Production
▪ M&A - Biologics CMO or CRO

eXCELL Biotherapeutics Inc.

For human and pet health, our mission is to design, develop and deliver the constructive xenogeneic cell immunotherapy to improve cancer patients’ outcomes.

ImmunAdd Inc.

▪ Out—Licensing
▪ Collaborative R&D

PrecisemAb Biotech Co., Ltd.

Collaborative R&D, CDMO, Distribution, Long-Term Partnership, Product Supply Agreement

ZIH YUAN TANG Biotechnology Co., Ltd.

We are looking for business partners, hoping to have more funds to enter preclinical animal tests and IND; or, Out-Licensing.
According to the authoritative Grand View Research report: In the NPDR stage, the global market will exceed US 10 billion annually.

Bora Biologics Co., Ltd.

BORA’s team is here to discuss how we can become a trusted partner to help bring your breakthrough biologics successfully to market utilizing our platform & unique developer experience.
▪ Biologics CDMO: Establishing Cell Line, Process Optimization, Analytical/Formulation Development, Tox Study Material, cGMP Manufacturing, Global Quality, Stability Programs, Clinical Support

China Medical University

▪ We are a biomedical start-up group striving to develop quality biomimetic medical innovations. With our own laboratory and medical device factory, international collaborative R&D and CDMO are direction of our business cooperation.
▪ We are delighted to discuss our development process and explore potential partnerships (co-development), out-licensing opportunities, CDMO, and CRO collaboration.

China Medical University Hospital

▪ In-/Out-Licensing: USFDA
▪ Collaborative R&D
▪ Data exchange cooperation
▪ Knowledge sharing and technical support

Research Center for Emerging Viral Infections, Chang Gung University, Taiwan

RCEVI offers a range of customized services, such as antiviral testing, validation of diagnostic kits, and vaccine/drug development. We have launched various products in Taiwan via out-licensing agreements and collaborate with research centers in Chang Gung University for high-quality R&D, emphasizing their core competencies in all the tests of viruses.

Show Chwan Healthcare System Center for MedTech Commercialization

▪ Collaborative R&D
With 9 hospitals and 1 most advanced surgery training center in Asia, we are interested in international collaborative R&D projects.
▪ CDMO
In partnership with Taiwan ICT industry, we bridge manufacturing resources for early-stage innovations.

Taipei Veterans General Hospital & ASUSTeK Computer Inc.

VGHTPE has interest in B2B collaboration with companies serving 200 or more hospitals. ASUS AICS is keen to collaborate with AI innovators and platform developers to create strong technology partnerships and continue providing revolutionary healthcare solutions.

Altek Biotechnology

Our company specializes in the design and manufacturing of wearable injectors for pharmaceutical and biotech companies.

Chang Gu biotechnology Co.,Ltd

▪ Out-Licensing
▪ Market agency authorization
▪ Acquisition investment

MedFluid Co,. Ltd.

▪ Direct import, sales to distributors or hospital (Human and veterinary market)
▪ Strategic partners (Local device and reagents GMP suppliers)
▪ CDMO using Integrated Lab-on-chip platform (Liquid biopsy, protein detection, veterinary diagnostics, food safety, Pesticide residue detection, Environmental test)

Neurobit Technologies Co., Ltd.

▪ Hospitals
▪ Distributors

PLEXBIO Co., Ltd

▪ Distributor
▪ RUO/ LDTs
▪ KOL Collaborations
▪ CDMO Services
▪ Technology Licensing

Smart Surgery technology Co., Ltd.

Our technology is licensed by Taipei Medical University.

SoundJet Medical, Inc.

▪ Out-Licensing
▪ Collaborative R&D
▪ CDMO
▪ CRO

WeMED Biotech Inc.

WeMED is seeking for distributors, collaborative sales, out-licensing, or collaborative R&D opportunities.

AcroCyte Therapeutics

▪ Looking for distributors for 3D culture market
▪ Targeting B2B or B2C clients who are interested in organoid/3D culture

CancerFree Biotech

▪ Joint Drug Discovery: Partnering for breakthrough research.
▪ U.S. Partners Wanted: Collaborating with CROs, pharma, and academia.
▪ Platform/Product Development: Transforming scientific breakthroughs into tangible advancements.

Elixiron Immunotherapeutics

▪ We plan to raise series B funding in 2H 2024 to accelerate the development of our clinical assets.
▪ We also welcome the opportunities of out-licensing or co-development.

Everfront Biotech

▪ Collaborative RD: US
▪ Out-licensing: Other countries

Health Ever Bio-Tech Co., Ltd.

• Out-Licensing
• Collaborative R&D

Hughes Biotechnology Co., Ltd.

PARTNERING OBJECTIVES
▪ Seeking collaborative opportunities in high-potent active ingredient development.
▪ Partnering on clinical studies.
▪ RenoSorbTM technology technical platform service

Oneness Biotech Co., Ltd.

Seeking out-licensing and collaborative R&D opportunities for first-in-class drugs based on innovative proprietary technology.

Pythia Biotech LTD

Collaborative R&D

Simpson Biotech Co., Ltd.

• Out-Licensing
• CDMO for recombinant proteins

Suntec Medical, Inc.

Initiate the business discussions for STM-001, 002, 003 licensing or collaborations (product handover after receiving FDA “breakthrough” designations).

Trust Bio-sonics Inc.

▪ Out-Licensing
▪ Collaborative R&D
▪ CDMO for Microbubble Formulation

TLC BioSciences

▪ Out-Licensing
▪ Collaborative R&D

Xantho Biotechnology Co., LTD

Out-Licensing
GM-XANTHO is available for out-licensing with rights in drug development and commercialization.

Agricultural Technology Research Institute

Collaborative R&D. We offer animal study can evaluate efficacy, toxicity study using pig model and bio-safety service to biotechnology companies. We want to contact the exhibitors help to screen potential candidate and accelerate new drug development.

Amaran Biotechnology, Inc.

CDMO service and Global Partnership for the cGMP manufacturing of critical substances and injectable products.
Collaborative R&D for new chemical/biologics entity entering clinical trial.

Formosa Laboratories,Inc.

▪ Out-licensing injectable products.
▪ API, fermentation, peptide, ADC, and injectable CDMO/CMO services

Mycenax Biotech Inc.

Mycenax is a fully dedicated bio-CDMO.
We also offer an open platform of novel technologies from our collaborators, such as ADCC enhancing technology (CHO pharma) and site-specific linkers for ADC, to enhance our customers’projects in terms of product quality and efficacy.

Praexisio Taiwan Inc.

Out-Licensing, Consultancy, Cross-Industry Alliance with System Integrator, Extended Bioinformatics Team to CDMO or pharma.

Biomedical Translation Research Center (BioTReC), Academia Sinica

▪ Collaborating with international bio-cluster/ bio-park, accelerator, incubation center, global pharma, government agency, biotech association, venture capital;
▪ Space for startup related new drug discovery, smart healthcare & precision medicine;
▪ Translational medical research cooperation;
▪ Core facility support

Central Taiwan Science Park

▪ Collaborative R&D
▪ CDMO

China Productivity Center

Seeking in-/out-licensing, collaborative R&D, CDMO opportunities for Taiwanese biotechnology and Medicine companies.

Department of Academia Industry Collaboration and Science Park Affairs National Science and Technology Council

▪ Innovation and entrepreneurship
▪ Academia-industry collaboration
▪ Startups
▪ Talent cultivation

Development Center for Biotechnology

Out-Licensing, Collaborative R&D

Industrial Technology Research Institute

▪ R&D Collaboration
▪ CDMO/ CRO
▪ Out-Licensing
▪ GxP Trial Production

National Health Research Institutes

▪ R&D Collaboration
▪ Licensing

National Science and Technology Council

▪ IP/Tech feasibility and analysis for pharmaceuticals and medical devices
▪ Prototyping service for pharmaceuticals and medical devices
▪ Marketing analysis and regulatory compliance support for pharmaceuticals and medical devices
▪ Accelerate commercialization for pharmaceuticals and medical devices

Southern Taiwan Science Park Bureau, National Science and Technology Council

Collaborative R&D, CDMO

Startup Island TAIWAN

Startup Island TAIWAN demonstrates the strong ambition and capabilities of Taiwan tech startups as well as their intention and ability to contribute to other startup ecosystems around the world. We hope to be your gateway to Taiwan’s startup ecosystem.

Taiwan Bio Industry Organization

BIO Asia–Taiwan International Conference and Exhibition

Taipei City Government

▪ Welcome Int`l bio companies to land in Taipei.

Academia Sinica

▪ Research cooperation
▪ Technology transfer
▪ Material Transfer

Asia Silicon Valley Development Agency (ASVDA)

Council of Agriculture, Executive Yuan, R.O.C

Hsinchu Science Park Bureau, National Science and Technology Council

▪ Providing top-tier infrastructure and comprehensive one-stop services.
▪ Promoting industry-academia R&D collaboration. Creating a cluster of innovative ventures in world arena.
▪ Creating a cluster of innovative ventures in world arena.

Industrial Development Bureau, Ministry of Economic Affairs

Medical and Pharmaceutical Industry Technology and Development Center

▪ Out-licensing of pharmaceutical technology, including hot-melt extrusion drugs, drug-eluting medical devices, botanical products, and stem cell products, to external parties.
▪ Collaborative clinical trials for stem cell products and botanical products.
▪ CDMO services for complex generic drug.

Ministry of Health and Welfare of the Republic of China

The MOHW’s diversified responsibilities include health policy planning and promotion, prevention and control of disease, food safety, drug management, social insurance and welfare, relief and protective services.

Taipei Exchange

TPEx aims to attract issuers to list securities, providing investors with a fair, transparent, and efficient market.

Taiwan Stock Exchange

The Office of Science and Technology Policy (OSTP), the National Science and Technology Council (NSTC)